Detalhe da pesquisa
1.
Neurocognitive correlates of metabolic dysregulation in individuals with mood disorders: a systematic review and meta-analysis.
Psychol Med;
54(7): 1245-1271, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38450447
2.
Depression in caregivers of patients with schizophrenia: a scoping review.
Soc Psychiatry Psychiatr Epidemiol;
59(1): 1-23, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37308691
3.
Glucose dysregulation in antipsychotic-naive first-episode psychosis: in silico exploration of gene expression signatures.
Transl Psychiatry;
14(1): 19, 2024 Jan 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38199991
4.
Promising translatable pharmacological interventions for body weight management in individuals with severe mental illness - a narrative review.
Expert Opin Pharmacother;
24(16): 1823-1832, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37653675
5.
Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series.
Ther Adv Psychopharmacol;
13: 20451253231165169, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37113745
6.
Pharmacological Interventions to Treat Antipsychotic-Induced Dyslipidemia in Schizophrenia Patients: A Systematic Review and Meta Analysis.
Front Psychiatry;
12: 642403, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33815174